Drilldown: Medicines
Appearance
Use the filters below to narrow your results.
generic:
brand:
mechanism:
None (50) ·
Mild to moderate pain; cough suppression (low-dose). (1) ·
Schizophrenia (FDA-approved 2015). Adjunctive treatment of major depressive disorder (2015). '''Agitation associated with dementia due to Alzheimer disease''' (FDA-approved May 2023, first agent specifically approved for this problem). Investigational for PTSD (combined with sertraline). (1)
Showing below up to 52 results in range #1 to #52.


